Coherus BioSciences ( NASDAQ:CHRS – Get Rating ) released its earnings results on Monday. The biotechnology company reported ($0.76) EPS for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.12), MarketWatch Earnings reports. Coherus BioSciences had a negative net margin of 138.24% and a negative return on equity of 422.10%. The firm had revenue of $45.35 million during the quarter, compared to analysts' expectations of $45.72 million. During the same quarter in the previous year, the business earned ($0.

https://www.dailypolitical.com/2023/03/08/coherus-biosciences-nasdaqchrs-posts-earnings-results-misses-expectations-by-0-12-eps.html

#dailypolitical